Metabolic reprogramming in the tumor microenvironment of liver cancer

被引:10
|
作者
Lin, Jian [1 ,4 ]
Rao, Dongning [2 ]
Zhang, Mao [2 ]
Gao, Qiang [1 ,2 ,3 ]
机构
[1] Fudan Univ, Jinshan Hosp, Ctr Tumor Diag & Therapy, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat,Key Lab Carcinogene, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Biomed Sci, Key Lab Med Epigenet & Metab, Shanghai 200032, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Liver cancer; Metabolic reprogramming; Immune microenvironment; Gut-liver axis; T-CELL METABOLISM; HEPATOCELLULAR-CARCINOMA; LACTIC-ACID; PROTEOGENOMIC CHARACTERIZATION; GLUCOSE TRANSPORTERS; ENHANCES SURVIVAL; SUPPRESSOR-CELLS; GUT MICROBIOME; DOUBLE-BLIND; PHASE-I;
D O I
10.1186/s13045-024-01527-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The liver is essential for metabolic homeostasis. The onset of liver cancer is often accompanied by dysregulated liver function, leading to metabolic rearrangements. Overwhelming evidence has illustrated that dysregulated cellular metabolism can, in turn, promote anabolic growth and tumor propagation in a hostile microenvironment. In addition to supporting continuous tumor growth and survival, disrupted metabolic process also creates obstacles for the anticancer immune response and restrains durable clinical remission following immunotherapy. In this review, we elucidate the metabolic communication between liver cancer cells and their surrounding immune cells and discuss how metabolic reprogramming of liver cancer impacts the immune microenvironment and the efficacy of anticancer immunotherapy. We also describe the crucial role of the gut-liver axis in remodeling the metabolic crosstalk of immune surveillance and escape, highlighting novel therapeutic opportunities.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
    Faraj, Jabar A.
    Al-Athari, Ali Jihad Hemid
    Mohie, Sharaf El Din
    Kadhim, Iman Kareem
    Jawad, Noor Muhsen
    Abbas, Weaam J.
    Jalil, Abduladheem Turki
    [J]. MEDICAL ONCOLOGY, 2022, 39 (12)
  • [42] Metabolic reprogramming of the tumour microenvironment
    Xing, Yazhi
    Zhao, Shimin
    Zhou, Binhua P.
    Mi, Jun
    [J]. FEBS JOURNAL, 2015, 282 (20) : 3892 - 3898
  • [43] Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
    Xia, Yujia
    Brown, Zachary J.
    Huang, Hai
    Tsung, Allan
    [J]. CANCER MEDICINE, 2021, 10 (18): : 6374 - 6383
  • [44] Metabolic reprogramming of the tumor microenvironment by p62 and its partners
    Reina-Campos, Miguel
    Shelton, Phillip M.
    Diaz-Meco, Maria T.
    Moscat, Jorge
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1870 (01): : 88 - 95
  • [45] A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022
    Xi, Yupeng
    Liu, Rui
    Zhang, Xing
    Guo, Qiujun
    Zhang, Xiwen
    Yang, Zizhen
    Zheng, Honggang
    Song, Qingqiao
    Hua, Baojin
    [J]. CANCER REPORTS, 2024, 7 (08)
  • [46] Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment
    Liu, Liang
    Huo, Shuping
    Liu, Jianghui
    Li, Qiaomin
    Wang, Jing
    [J]. DISCOVERY MEDICINE, 2021, 31 (164) : 141 - 146
  • [47] Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
    Cheng, Hua
    Zheng, Yongbin
    [J]. PEERJ, 2024, 12
  • [48] Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment
    Mikkilineni, Lekha
    Whitaker-Menezes, Diana
    Domingo-Vidal, Marina
    Sprandio, John
    Avena, Paola
    Cotzia, Paolo
    Dulau-Florea, Alina
    Gong, Jerald
    Uppal, Guldeep
    Zhan, Tingting
    Leiby, Benjamin
    Lin, Zhao
    Pro, Barbara
    Sotgia, Federica
    Lisanti, Michael P.
    Martinez-Outschoorn, Ubaldo
    [J]. SEMINARS IN ONCOLOGY, 2017, 44 (03) : 218 - 225
  • [49] Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
    Zanoni, Michele
    da Silva, Henrique Borges
    Adinolfi, Elena
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [50] Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
    Varun Sasidharan Nair
    Reem Saleh
    Salman M. Toor
    Farhan S. Cyprian
    Eyad Elkord
    [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 2123 - 2123